Abstract
Serological assays can reveal immune status against COVID-19 informing individual and public healthcare decisions. We report a multiplexed and label-free nanoplasmonic biosensor that can discriminate healthy from convalescent samples with high sensitivity (95%) and specificity (100%) based on anti-SARS-CoV-2 antibody quantification. Our results show high concordance (R~ 0.87) with commercial assays in detecting anti-SARS-CoV-2 antibodies.
© 2022 The Author(s)
PDF Article | Presentation VideoMore Like This
Agostino Occhicone, Alberto Sinibaldi, Tommaso Pileri, Paola Di Matteo, Daniele Chiappetta, Peter Munzert, Norbert Danz, Frank Sonntag, Matteo Allegretti, Valentina De Pascale, Chiara Mandoj, Laura Conti, and Francesco Michelotti
FTh1D.1 Frontiers in Optics (FiO) 2022
Arieh Grosman, Tal Duanis-Assaf, Noa Mazurski, Liron Stern, Meital Reches, and Uriel Levy
SM3L.8 CLEO: Science and Innovations (CLEO:S&I) 2022
Sartanee Suebka, Adley Gin, Yisha Tang, Soo-Kyung Kim, William A. Goddard, and Judith Su
AM2I.5 CLEO: Applications and Technology (CLEO:A&T) 2022